Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
25.76
+2.67 (11.56%)
At close: Mar 9, 2026, 4:00 PM EDT
24.21
-1.55 (-6.02%)
After-hours: Mar 9, 2026, 4:02 PM EDT

Greenwich LifeSciences Market Cap

Greenwich LifeSciences has a market cap or net worth of $358.56 million as of March 9, 2026. Its market cap has increased by 126.56% in one year.

Market Cap
358.56M
Enterprise Value
318.08M
1-Year Change
126.56%
Ranking
Category
Stock Price
$25.76

Market Cap Chart

Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $358.56M, an increase of 422.01%. That is a compound annual growth rate of 35.45%.

History

DateMarket Cap% Change
Mar 6, 2026319.90M9.90%
Dec 31, 2025291.08M97.19%
Dec 31, 2024147.61M9.21%
Dec 29, 2023135.16M-30.79%
Dec 30, 2022195.29M-38.84%
Dec 31, 2021319.29M-31.08%
Dec 31, 2020 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Opus Genetics 337.23M
Adlai Nortye 328.78M
X4 Pharmaceuticals 328.76M
Relmada Therapeutics 326.33M
Rezolute 323.04M
Avalo Therapeutics 320.46M
Protara Therapeutics 316.16M
Nautilus Biotechnology 312.61M
Market Cap Rankings